Contraceptive Devices: A Leading Driver Behind Rising Prevalence Of STDs Propels The Contraceptive Devices Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Contraceptive Devices Industry Market Size Be by 2025?
In the last few years, the market size for contraceptive devices has seen significant growth. The projection is for it to increase from $12.8 billion in 2024 to $13.66 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. This growth during the historical period can be credited to heightened awareness about family planning and contraceptive use importance, government undertakings, an upsurge in global population, enhanced emphasis on women's health and empowerment, and improvements in healthcare facility accessibility.

What's the Long-Term Growth Forecast for the Contraceptive Devices Market Size Through 2029?
The market for contraceptive devices is anticipated to experience substantial expansion in the upcoming years, with an expectation to reach $17.47 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.4%. The projected growth during this period is credited to enhanced understanding of sexual health and the prevention of STDs, the economic advantages of family planning, increasing societal approval of contraceptive use, a high number of young individuals of reproductive age, and the impact of social media in expanding awareness. The forecast period is envisioned to be influenced by trends such as the development of novel contraceptive technologies, instructional campaigns conducted by NGOs and health institutions, advancements in pharmaceutical compositions, a broad array of contraceptive products, and investments in research and development for innovative contraceptive techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

What Are the Key Growth Drivers Fueling the Contraceptive Devices Market Expansion?
The escalating instances of sexually transmitted diseases (STDs) are anticipated to spur the expansion of the contraceptive device market. STDs, primarily passed on through sexual contact, can affect various body parts and possibly lead to different symptoms and health issues. The rise in STDs is attributed to increased sexual activity, inadequate protection, lack of comprehensive sexual health education, and hurdles in accessing healthcare and testing. Contraceptive devices, particularly condoms, are vital in combating STDs as they provide a barrier that minimises transmission risk by preventing direct exposure to infectious fluids and sores. For instance, a report published by the UK Health Security Agency in July 2024 revealed that in England, there were 401,800 new STI diagnoses in 2023, indicating a 4.7% rise from the 383,789 cases noted in 2022. Gonorrhea diagnoses increased by 7.5%, going up from 79,268 in 2022 to 85,223 in 2023. Simultaneously, diagnoses of infectious syphilis saw a surge of 9.4%, advancing from 8,693 in 2022 to 9,513 in 2023. Thus, the escalating prevalence of sexually transmitted diseases is fuelling the expansion of the contraceptive device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Are the Key Trends Driving Contraceptive Devices Market Growth?
Leading organizations in the contraceptive device sector are introducing new product advancements like contraceptive vaginal rings, providing a practical, hassle-free, monthly birth control option. These contraceptive vaginal rings are pliable, hormone-releasing devices placed inside the vagina to avoid pregnancy by steadily releasing hormones to stop ovulation and increase the density of cervical mucus. For example, in October 2023, Xiromed LLC, a pharmaceutical company based in the United States, introduced the EnilloRing. Xiromed's EnilloRing is a contraceptive vaginal ring that integrates etonogestrel and ethinyl estradiol and is meant to remain in place for three weeks for long-term use. A one-week ring-free interval follows this to ensure effective prevention of pregnancy.

How Is the Contraceptive Devices Market Segmented?
The contraceptive devices market covered in this report is segmented -

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types
2) By Technology: Hormonal Contraceptives, Barrier Contraceptives
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:
1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills
2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices
3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms
4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges
5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings
6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs
7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants
8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Which Companies Are Leading the Charge in Contraceptive Devices Market Innovation?
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Which Regions Are Leading the Global Contraceptive Devices Market in Revenue?
North America was the largest region in the contraceptive devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18320

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.